Press release

e-therapeutics to present at BioCentury Summit

12 November 2018

The summit will be held on 13th – 14th November at the Jing An Shangri-La in Shanghai, China.

Dr Ray Barlow, Chief Executive Officer of e-therapeutics, will be presenting an overview of the Company at 13:30 on 13th November in the UK Biotech Track Panel and will be available to take questions following the event.

Tags
Share
Sign up for press releases

Discover

Whats New?

Explore more

Tangram Therapeutics Announces First Participant Dosed in Phase 1/2 RESTORE-MASH Trial of TGM-312, a Novel Investigational RNAi Medicine

Mar 5, 2026

Tangram Therapeutics Submits Clinical Trial Application for Phase 1/2 Study of TGM-312, a Novel Investigational RNAi MASH Candidate

Nov 26, 2025

Tangram Therapeutics to Participate in Upcoming Investor and Scientific Conferences

Oct 3, 2025

e-therapeutics Relaunches as Tangram Therapeutics and Unveils LLibra OS

Oct 1, 2025

e-therapeutics De-risks Clinical Path for GalOmic Candidate ETX-312 with Positive Non-clinical Data

Jul 10, 2025

e-therapeutics presents new data supporting ETX‑312 as a differentiated, disease-modifying near-clinic GalOmic Treatment for MASH

May 7, 2025

/